Momoney54:


We are waiting for MSCI to finish selling off here like they said they were going to do for ETI. When they finish we will key in and they will come buy it from us...

It's alright.
...pls be waiting oo !!

onegentleguy:
Again ETI is a strong BUY @ the current mkt price !!

The stock is currently playing out the statement in italics;

"When u see an asset of VALUE where the plausible rate of return/REWARD(MoS against potential ROI in view) has run @ a much faster pace than(@ premium to) the SUM OF its PRICE and surrounding RISK, RUN IN, because PRICE 'is ready' to chase VALUE !!

That coy can well return near 130%(ROI) from the current price level.

Enough said.

special center personified. Where expo is written on the board

onegentleguy:




Abeg help me send that meat-pie and cake along...

You want that oven to burn my hand abi?
It is too hot to try to pick out anything from inside now....

DeRuggedProf:


Ignition, Engine, Typical................

On 6.52% gain now.

@ Mercy,hope you are still holding your chams?
Cp wanted you to consider ikeja hotel before chams.Well everything na turn by turn.

@mpeace,keep having patience on wapco.You will enjoy it than fbn

Toluway:

Tribute to you for your pragmatic, selfless, charismatic, straightforward, direct and bold contributions. You are a leader indeed, a celebrity. God bless you.

God bless you too

You have the eyes of the eagle.

That guy (OGG) is somebody.

DeRuggedProf:


After you take loss from Wapco run to FBNH. everything will reverse, Wapco will start rallying, FBNH will then start ranging.....

I no go sell any of them. I must chop all.
It happened to me once, it will never happen again.

Meritrade website interface acting funny...anybody with same problem?

onegentleguy:
NEIMETH PHARMACEUTICALS might soon go on full bid !!
...it has now returned approx 20% btw yesterday and today riding from 40k to 48k at the moment.
We called for this 'guy' when it was still trading for 38k.

The feasible REWARD pegged side by side with the decelerating surrounding RISK(tax incentives, cost drawdown and plausible growth margin in view) paints of an asset with an underpriced stance.

NOTE: NOT a buy recommendation. ...following ur instinct should still take higher precedence ahead of this post.

It is well.

On NEIMITH, trust we remember that the company is of an international status with business/investment spread accross 4 francophone countries(the Gambia, Ghana, Sierra Leone and Liberia) aside Nigeria.

Some of their product within the pharmaceutical line of business like CIKLAVIT(used for the management of sickle cell disease), NCP and Homtamin G is now among the high selling ethical and consumer line product in the 5 African countries(including Nigeria) they currently operate.

The company also plays in the Veterinary(animal-related) business space with several product brands spread accross that chain.

Looking at their last 3 financial print(YE 2018 to Q3 2019 in view) though appears to be poor, it gave some insight on the drive for better growth margin.
...and when u benchmark the coys sorrounding RISK to the match of PRICE and FVE, u would see that feasible REWARD has since overtaking it(risk-return from MoS peg in view)
Like I always tell folks;

When u see a bad result reveal clear signs of accelerating REWARD compared to decelerating surrounding RISK and feasible MoS return runs ahead of the match of price against FVE, run in and ask questions later !!
Alternatively, when u see a good result reveal signs of decelerating REWARD when benchmarked with surrounding risk while price runs faster than the match of feasible MoS return against FVE, run with ur two legs touching ur head !!

Bottom line: The stock is a buy @ current mkt price.

CAVEAT: NOT to be interpreted as any sought of recommendation. ...following ur instinct should still take higher precedence ahead of this post.

onegentleguy:


On NEIMITH, trust we remember that the company is of an international status with business/investment spread accross 4 francophone countries(the Gambia, Ghana, Sierra Leone and Liberia) aside Nigeria.

Some of their product within the pharmaceutical line of business like CIKLAVIT(used for the management of sickle cell disease), NCP and Homtamin G is now among the high selling ethical and consumer line product in the 5 African countries(including Nigeria) they currently operate.

The company also plays in the Veterinary(animal-related) business space with several product brands spread accross that chain.

Looking at their last 3 financial print(YE 2018 to Q3 2019 in view) though appears to be poor, it gave some insight on the drive for better growth margin.
...and when u benchmark the coys sorrounding RISK to the match of PRICE and FVE, u would see that feasible REWARD has since overtaking it(risk-return from MoS peg in view)

Bottom line: The stock is a buy @ current mkt price.

CAVEAT: NOT to be interpreted as any sought of recommendation. ...following ur instinct should still take higher precedence ahead of this post.

OGG is a good analyst and researcher. This my space. I can agree that Neimeth is going to do well. They just need to polish their management a bit. You didn't mention Normoretic. That product sells like paracetamol. I wish them well.

Fidson is another cash cow. Those guys products from Astymin, Astyfer, Ciprotab and Addyzoa are wildly consumed in the pharma space. If not for expansion and mismanagement, Fidson should be giving us higher numbers in their financial reports.

FBNH gathering more energy. 44M bids against 10 now.....
Where is tritritri self?
FBN about to overtake UBA. Elephant claiming its right by all means.

PharmAlfred:


OGG is a good analyst and researcher. This my space. I can agree that Neimeth is going to do well. They just need to polish their management a bit. You didn't mention Normoretic. That product sells like paracetamol. I wish them well.

Fidson is another cash cow. Those guys products from Astymin, Astyfer, Ciprotab and Addyzoa are wildly consumed in the pharma space. If not for expansion and mismanagement, Fidson should be giving us higher numbers in their financial reports.

Then add that to the fact that surrounding RISK has been decelerating(tax incentives, cost drawdown and plausible growth margin in view), and ur guess should be as good as mine when time 'forces' PRICE to chase VALUE !!

It is well.

UBA 7.50, FBN 7.45.......................Who's the boss? We are observing.

FBNH almost take over ..Too much laziness not good

lancee:
FBNH almost take over ..Too much laziness not good

Elephant will soon crush it out of its way.

PharmAlfred:


OGG is a good analyst and researcher. This my space. I can agree that Neimeth is going to do well. They just need to polish their management a bit. You didn't mention Normoretic. That product sells like paracetamol. I wish them well.

Fidson is another cash cow. Those guys products from Astymin, Astyfer, Ciprotab and Addyzoa are wildly consumed in the pharma space. If not for expansion and mismanagement, Fidson should be giving us higher numbers in their financial reports.

But he can't follow a hunter to the bush without a fight, he coughs too much....
He stirs up too much DUST as well....

locodemy:
@ Mercy,hope you are still holding your chams?
Cp wanted you to consider ikeja hotel before chams.Well everything na turn by turn.

Ikeja is illiquid unlike chams. So I rather went for Chams..... I sold part of it, remaining small. Will wait for pullback again.

FBNH don vex o

lancee:
FBNH don vex o

7.85 now...

It have happened. FBNH don't pass UBA. We chasing Access.

Mcy56:

Ikeja is illiquid unlike chams. So I rather went for Chams..... I sold part of it, remaining small. Will wait for pullback again.

Good call.
For jijoists, this is the beginning of wisdom.

onegentleguy:


PZ plans to delist from the Ghana stock exchange.
...Nigeria could be next.(just a NOTE to the part in bold)

https://businesspost.ng/economy/pz-cussons-announces-plan-to-delist-from-stock-exchange/

On PZ Ghana Plc...

"In a disclosure last month, PZ Cussons explained that the decision to delist from the Ghana stock exchange was buoyed by its plans to achieve operational efficiency, by providing management of the company more time and resources to focus on running and expanding the business, its distribution network and reach, thereby ensuring consumer satisfaction."

On PZ Nig Plc...
In a statement coined from the Chairman's address(last AGM in view);

"To ensure we sustain and continue to grow our position, we have resolved to focus on Fewer, Bigger and Better initiatives...
The focus for our trading brands will be to drive costs down whilst delivering product performance to ensure we are able to compete and retain the critical mass required to support our key focus brand"

Why do I sense a connection with this 2 post and the part in bold above.

...we continue to observe.

. .

....

FCMB on the move................

OakPearl:
Some people got tired of waiting for FCMB result and sprayed N2.10 on several thousand shares.
Time to find a higher support level.

People have seen the result walahi.
This one is on power horse + alomo bitters!

Mpeace:
It have happened. FBNH don't pass UBA. We chasing Access.

Waiting at N10.00 junction.

Mcy56:
FCMB on the move................

I don hammer wella for this one and fidelity.

Wapco and Uacn can wait a bit.

Zenith the slow horse...smh...porting tomorrow...

DeRuggedProf:


But he can't follow a hunter to the bush without a fight, he coughs too much....
He stirs up too much DUST as well....

Hahahaha. Prof Prof. Leave OGG alone na.
Meanwhile, which stocks should we key into now?

locodemy:
I don hammer wella for this one and fidelity.
Wapco and Uacn can wait a bit.

Lucky you.

Homextras:
Zenith the slow horse...smh...porting tomorrow...

You can play other stocks and come back for it adding more units than before.Still my aim this time around.

Go and check peterichy's meme yesterday,you will understand.